Which has better valuation and earnings, GH or RDNT?

RadNet has higher revenue and earnings than Guardant Health. RadNet is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 21.53 -$416.28M -$3.49 N/A RadNet $2.04B 3.00 -$18.65M -$0.27 N/A

Does the media refer more to GH or RDNT?

In the previous week, RadNet had 5 more articles in the media than Guardant Health. MarketBeat recorded 23 mentions for RadNet and 18 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.94 beat RadNet's score of 0.92 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 11 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 9 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to FMS or RDNT?

In the previous week, RadNet had 18 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 23 mentions for RadNet and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.35 beat RadNet's score of 0.92 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 9 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BTSG or RDNT?

In the previous week, RadNet had 11 more articles in the media than BrightSpring Health Services. MarketBeat recorded 23 mentions for RadNet and 12 mentions for BrightSpring Health Services. RadNet's average media sentiment score of 0.92 beat BrightSpring Health Services' score of 0.84 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 5 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 9 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, DVA or RDNT?

DaVita has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DaVita $13.64B 0.85 $746.80M $12.22 14.85 RadNet $2.04B 3.00 -$18.65M -$0.27 N/A

Is DVA or RDNT more profitable?

DaVita has a net margin of 6.05% compared to RadNet's net margin of -0.93%. RadNet's return on equity of 2.64% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets DaVita 6.05% -217.63% 5.07% RadNet -0.93% 2.64% 0.94%

Does the media favor DVA or RDNT?

In the previous week, RadNet had 14 more articles in the media than DaVita. MarketBeat recorded 23 mentions for RadNet and 9 mentions for DaVita. RadNet's average media sentiment score of 0.92 beat DaVita's score of 0.64 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 9 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, TEM or RDNT?

RadNet has higher revenue and earnings than Tempus AI. RadNet is trading at a lower price-to-earnings ratio than Tempus AI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tempus AI $1.27B 7.48 -$245.03M -$1.44 N/A RadNet $2.04B 3.00 -$18.65M -$0.27 N/A

Is TEM or RDNT more profitable?

RadNet has a net margin of -0.93% compared to Tempus AI's net margin of -17.77%. RadNet's return on equity of 2.64% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets Tempus AI -17.77% -50.28% -10.33% RadNet -0.93% 2.64% 0.94%

Does the media refer more to TEM or RDNT?

In the previous week, RadNet had 16 more articles in the media than Tempus AI. MarketBeat recorded 23 mentions for RadNet and 7 mentions for Tempus AI. RadNet's average media sentiment score of 0.92 beat Tempus AI's score of 0.65 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 9 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

RadNet (RDNT) Competitors

$77.72 +0.41 (+0.52%)

As of 10:46 AM Eastern

Compare

RDNT vs. GH, FMS, BTSG, DVA, and TEM

Should you buy RadNet stock or one of its competitors? RadNet's main competitors and comparable companies include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), DaVita (DVA), and Tempus AI (TEM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does RadNet compare to Guardant Health?

Guardant Health (NASDAQ:GH) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends.

In the previous week, RadNet had 5 more articles in the media than Guardant Health. MarketBeat recorded 23 mentions for RadNet and 18 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.94 beat RadNet's score of 0.92 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	11 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	9 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has a net margin of -0.93% compared to Guardant Health's net margin of -38.33%. RadNet's return on equity of 2.64% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
RadNet	-0.93%	2.64%	0.94%

Guardant Health presently has a consensus target price of $183.78, suggesting a potential upside of 16.64%. RadNet has a consensus target price of $88.00, suggesting a potential upside of 13.23%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts clearly believe Guardant Health is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
RadNet	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.78

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

RadNet has higher revenue and earnings than Guardant Health. RadNet is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	21.53	-$416.28M	-$3.49	N/A
RadNet	$2.04B	3.00	-$18.65M	-$0.27	N/A

Guardant Health has a beta of 1.6, suggesting that its stock price is 60% more volatile than the broader market. Comparatively, RadNet has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market.

Summary

Guardant Health beats RadNet on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market. Comparatively, RadNet has a beta of 1.36, suggesting that its share price is 36% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $23.57, suggesting a potential downside of 0.66%. RadNet has a consensus target price of $88.00, suggesting a potential upside of 13.23%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55
RadNet	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.78

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to RadNet's net margin of -0.93%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
RadNet	-0.93%	2.64%	0.94%

In the previous week, RadNet had 18 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 23 mentions for RadNet and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.35 beat RadNet's score of 0.92 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	9 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$19.43B	0.66	$1.11B	$1.93	12.29
RadNet	$2.04B	3.00	-$18.65M	-$0.27	N/A

Summary

RadNet beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

BrightSpring Health Services has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market. Comparatively, RadNet has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market.

In the previous week, RadNet had 11 more articles in the media than BrightSpring Health Services. MarketBeat recorded 23 mentions for RadNet and 12 mentions for BrightSpring Health Services. RadNet's average media sentiment score of 0.92 beat BrightSpring Health Services' score of 0.84 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	9 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

77.9% of RadNet shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Comparatively, 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

BrightSpring Health Services has a net margin of 2.55% compared to RadNet's net margin of -0.93%. BrightSpring Health Services' return on equity of 16.73% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.55%	16.73%	5.24%
RadNet	-0.93%	2.64%	0.94%

BrightSpring Health Services has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.94	$190.67M	$1.66	36.81
RadNet	$2.04B	3.00	-$18.65M	-$0.27	N/A

BrightSpring Health Services currently has a consensus target price of $70.71, suggesting a potential upside of 15.70%. RadNet has a consensus target price of $88.00, suggesting a potential upside of 13.23%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts plainly believe BrightSpring Health Services is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10
RadNet	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.78

Summary

BrightSpring Health Services beats RadNet on 11 of the 16 factors compared between the two stocks.

How does RadNet compare to DaVita?

DaVita (NYSE:DVA) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

In the previous week, RadNet had 14 more articles in the media than DaVita. MarketBeat recorded 23 mentions for RadNet and 9 mentions for DaVita. RadNet's average media sentiment score of 0.92 beat DaVita's score of 0.64 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	9 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

90.1% of DaVita shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 1.9% of DaVita shares are held by company insiders. Comparatively, 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

DaVita has a net margin of 6.05% compared to RadNet's net margin of -0.93%. RadNet's return on equity of 2.64% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.05%	-217.63%	5.07%
RadNet	-0.93%	2.64%	0.94%

DaVita has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, RadNet has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

DaVita currently has a consensus price target of $221.75, suggesting a potential upside of 22.16%. RadNet has a consensus price target of $88.00, suggesting a potential upside of 13.23%. Given DaVita's higher probable upside, equities analysts clearly believe DaVita is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
RadNet	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.78

DaVita has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	0.85	$746.80M	$12.22	14.85
RadNet	$2.04B	3.00	-$18.65M	-$0.27	N/A

Summary

RadNet beats DaVita on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to Tempus AI?

Tempus AI (NASDAQ:TEM) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Tempus AI has a beta of 3.58, indicating that its stock price is 258% more volatile than the broader market. Comparatively, RadNet has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

RadNet has a net margin of -0.93% compared to Tempus AI's net margin of -17.77%. RadNet's return on equity of 2.64% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
RadNet	-0.93%	2.64%	0.94%

Tempus AI currently has a consensus target price of $64.92, indicating a potential upside of 23.16%. RadNet has a consensus target price of $88.00, indicating a potential upside of 13.23%. Given Tempus AI's higher probable upside, equities research analysts clearly believe Tempus AI is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41
RadNet	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.78

RadNet has higher revenue and earnings than Tempus AI. RadNet is trading at a lower price-to-earnings ratio than Tempus AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	7.48	-$245.03M	-$1.44	N/A
RadNet	$2.04B	3.00	-$18.65M	-$0.27	N/A

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by insiders. Comparatively, 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, RadNet had 16 more articles in the media than Tempus AI. MarketBeat recorded 23 mentions for RadNet and 7 mentions for Tempus AI. RadNet's average media sentiment score of 0.92 beat Tempus AI's score of 0.65 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	9 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

RadNet beats Tempus AI on 11 of the 17 factors compared between the two stocks.

Get RadNet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDNT vs. The Competition

Export

Metric	RadNet	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$6.12B	$9.82B	$6.96B	$13.10B
Dividend Yield	N/A	2.55%	2.58%	10.72%
P/E Ratio	-287.82	35.22	269.57	25.32
Price / Sales	3.00	4.80	595.01	100.00
Price / Cash	23.87	124.00	70.53	50.75
Price / Book	4.42	5.34	13.06	6.29
Net Income	-$18.65M	$309.96M	$3.45B	$347.70M
7 Day Performance	7.36%	0.12%	0.47%	0.89%
1 Month Performance	23.79%	0.54%	1.11%	0.85%
1 Year Performance	13.04%	20.02%	66.38%	20.25%

RadNet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDNT RadNet	3.0713 of 5 stars	$77.72 +0.5%	$88.00 +13.2%	+13.0%	$6.12B	$2.04B	N/A	11,264	Earnings Report Analyst Forecast
GH Guardant Health	3.1075 of 5 stars	$167.21 -0.8%	$183.78 +9.9%	+172.4%	$22.61B	$982.02M	N/A	2,506	Insider Trade Gap Up
FMS Fresenius Medical Care AG & Co. KGaA	3.1675 of 5 stars	$24.33 +0.2%	$23.57 -3.1%	-5.0%	$13.04B	$22.20B	12.61	1,488	Positive News
BTSG BrightSpring Health Services	4.9591 of 5 stars	$61.45 -1.6%	$70.71 +15.1%	+169.0%	$12.35B	$12.91B	37.02	23,500	Analyst Forecast
DVA DaVita	4.7621 of 5 stars	$183.42 -0.2%	$221.75 +20.9%	+33.0%	$11.72B	$13.64B	15.01	78,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDNT) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RadNet (RDNT) Competitors

RDNT vs. GH, FMS, BTSG, DVA, and TEM

How does RadNet compare to Guardant Health?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does RadNet compare to BrightSpring Health Services?

Summary

How does RadNet compare to DaVita?

Summary

How does RadNet compare to Tempus AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RadNet (RDNT) Competitors

RDNT vs. GH, FMS, BTSG, DVA, and TEM

How does RadNet compare to Guardant Health?

Does the media refer more to GH or RDNT?

Is GH or RDNT more profitable?

Do analysts rate GH or RDNT?

Do institutionals and insiders have more ownership in GH or RDNT?

Which has better valuation and earnings, GH or RDNT?

Which has more risk and volatility, GH or RDNT?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Which has more volatility & risk, FMS or RDNT?

Do analysts recommend FMS or RDNT?

Do insiders & institutionals have more ownership in FMS or RDNT?

Is FMS or RDNT more profitable?

Does the media refer more to FMS or RDNT?

Which has preferable valuation & earnings, FMS or RDNT?

Summary

How does RadNet compare to BrightSpring Health Services?

Which has more risk & volatility, BTSG or RDNT?

Does the media favor BTSG or RDNT?

Do insiders & institutionals believe in BTSG or RDNT?

Is BTSG or RDNT more profitable?

Which has better earnings and valuation, BTSG or RDNT?

Do analysts recommend BTSG or RDNT?

Summary

How does RadNet compare to DaVita?

Does the media favor DVA or RDNT?

Do institutionals & insiders believe in DVA or RDNT?

Is DVA or RDNT more profitable?

Which has more volatility & risk, DVA or RDNT?

Do analysts rate DVA or RDNT?

Which has higher earnings and valuation, DVA or RDNT?

Summary

How does RadNet compare to Tempus AI?

Which has more volatility and risk, TEM or RDNT?

Is TEM or RDNT more profitable?

Do analysts recommend TEM or RDNT?

Which has stronger valuation & earnings, TEM or RDNT?

Do institutionals and insiders have more ownership in TEM or RDNT?

Does the media refer more to TEM or RDNT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools